OP0184 A TREATMENT STRATEGY COMBINING TNF-INHIBITOR, METHOTREXATE AND STEROIDS IS NOT SUPERIOR TO ME...
OP0184 A TREATMENT STRATEGY COMBINING TNF-INHIBITOR, METHOTREXATE AND STEROIDS IS NOT SUPERIOR TO METHOTREXATE AND STEROIDS IN EARLY PSORIATIC ARTHRITIS: RESULTS FROM THE GOLMEPSA RANDOMISED, DOUBLE-BLIND CLINICAL TRIAL
About this item
Full title
Author / Creator
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
Background:The optimal treatment strategy in Psoriatic Arthritis (PsA) is unknown despite the growing number of therapies available. Current European guidance on first line treatment recommends a step-up approach with methotrexate (MTX) or other conventional synthetic Disease Modifying Anti-Rheumatic Drugs (csDMARDs). The hypothesis underpinning th...
Alternative Titles
Full title
OP0184 A TREATMENT STRATEGY COMBINING TNF-INHIBITOR, METHOTREXATE AND STEROIDS IS NOT SUPERIOR TO METHOTREXATE AND STEROIDS IN EARLY PSORIATIC ARTHRITIS: RESULTS FROM THE GOLMEPSA RANDOMISED, DOUBLE-BLIND CLINICAL TRIAL
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3086348191
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3086348191
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2024-eular.544
